Indian pharmaceuticals: A long-term story

Read more

Improved awareness will lead to better business

Read more

Indian clinical research: A call to self regulate

Read more

Indian pharma: Emerging as global power in R&D

Read more

Tech solutions to improve management of drug development programmes

Read more

IPR trends in 2013: An alloy of problems and solutions

Read more

Transformational change in 2013

Read more

Modest progress in fiscal and public sector reforms expected

Read more

IPM grows 4.1 per cent, valued at Rs 5939 crore in November ‘12

Read more

State drug regulators equally responsible for clinical trial activities: DCGI

Read more